作者: N. Bellamy , W. W. Buchanan
DOI: 10.1007/BF02032334
关键词:
摘要: Outcome measures for clinical trials to be valid and reliable should also responsive change. There are currently no standardised methods of measuring the outcome in osteoarthritis trials. A review 63 nonsteroidal anti-inflammatory drugs revealed a large degree variability items, instruments scales employed. The implications this discussed proposed rationalising measurement area research.